Rhabdoid meningioma

Changed by Patrick J Rock, 22 May 2021

Updates to Article Attributes

Body was changed:

Rhabdoid meningioma is a rare and aggressive subtype of meningioma, it is classified as WHO grade III. Rhabdoid morphology is associated with a poor prognosis, regardless of tumour histogenesis. It resembles other types of rhabdoid tumours with a great tendency for recurrence 1,2. Extensive necrosis in rhabdoid meningioma might be indicative of an additional predictor of aggressive clinical behaviour 3.

Epidemiology

It occurs in middle age group approximately 10 years earlier than typical meningioma. Like benign meningioma, there is a slightly increased predominance in females and in African Americans 2

Clinical presentation

The presentation depends on the location of the lesion. Headache, seizures, visual manifestations, and focal neurological deficits have been described.

Pathology 

The term rhabdoid morphology is referring to the characteristic resemblance of the cells to a rhabdomyoblast without true skeletal muscle differentiation. The term malignant rhabdoid tumour (MRT) was first used to describe a distinctive paediatric renal tumour, the term was applied to similar extra-renal paediatric tumours. Rhabdoid cells show abundant eosinophilic cytoplasm, cytoplasmic hyaline inclusions, and eccentric nuclei 4

Grading

Generally, classified as WHO III malignant meningioma.

Radiographic features

Rhabdoid meningioma tends to have cystic and solid components with homogenoushomogeneous enhancement of the solid component. There is extensive peri-tumoural oedema 2. Bone destruction, indistinct margins and central necrosis are known to correlate with aggressiveness. 

MRI

Signal characteristics that correlate with aggressive behaviour of meningiomas include:

  • T1: indistinct tumour border (saw teeth appearance of the margins) and marked mass effect
  • T2/FLAIR: marked peri-tumuoral oedema
  • DWI/ADC: hyperintense signals on DWI that show restricted diffusion on ADC correlate with hypercellularity and more aggressive behaviour
  • T1 C+ (Gd): avid enhancement that may extend into the bone if associated with bone destruction
  • MR spectroscopy: an elevated level of alanine at short TE

Treatment and prognosis

The tumours have a tendency for recurrence and have a poor prognosis.

  • -<p><strong>Rhabdoid meningioma</strong> is a rare and aggressive subtype of <a href="/articles/meningioma">meningioma</a>, it is classified as WHO grade III. Rhabdoid morphology is associated with a poor prognosis, regardless of tumour histogenesis. It resembles other types of rhabdoid tumours with a great tendency for recurrence<sup> 1,2</sup>. Extensive necrosis in rhabdoid meningioma might be indicative of an additional predictor of aggressive clinical behaviour <sup>3</sup>.<!--EndFragment--></p><h4>Epidemiology</h4><p>It occurs in middle age group approximately 10 years earlier than typical meningioma. Like benign meningioma, there is a slightly increased predominance in females and in African Americans <sup>2</sup>. </p><h4>Clinical presentation</h4><p>The presentation depends on the location of the lesion. Headache, seizures, visual manifestations, and focal neurological deficits have been described.</p><h4>Pathology </h4><p>The term rhabdoid morphology is referring to the characteristic resemblance of the cells to a rhabdomyoblast without true skeletal muscle differentiation. The term malignant rhabdoid tumour (MRT) was first used to describe a distinctive paediatric renal tumour, the term was applied to similar extra-renal paediatric tumours. Rhabdoid cells show abundant eosinophilic cytoplasm, cytoplasmic hyaline inclusions, and eccentric nuclei <sup>4</sup>. </p><h6>Grading</h6><p>Generally, classified as WHO III malignant meningioma.</p><h4>Radiographic features</h4><p>Rhabdoid meningioma tends to have cystic and solid components with homogenous enhancement of the solid component. There is extensive peri-tumoural oedema <sup>2</sup>. Bone destruction, indistinct margins and central necrosis are known to correlate with aggressiveness. </p><h5>MRI</h5><p>Signal characteristics that correlate with aggressive behaviour of meningiomas include:</p><ul>
  • +<p><strong>Rhabdoid meningioma</strong> is a rare and aggressive subtype of <a href="/articles/meningioma">meningioma</a>, it is classified as WHO grade III. Rhabdoid morphology is associated with a poor prognosis, regardless of tumour histogenesis. It resembles other types of rhabdoid tumours with a great tendency for recurrence<sup> 1,2</sup>. Extensive necrosis in rhabdoid meningioma might be indicative of an additional predictor of aggressive clinical behaviour <sup>3</sup>.<!--EndFragment--></p><h4>Epidemiology</h4><p>It occurs in middle age group approximately 10 years earlier than typical meningioma. Like benign meningioma, there is a slightly increased predominance in females and in African Americans <sup>2</sup>. </p><h4>Clinical presentation</h4><p>The presentation depends on the location of the lesion. Headache, seizures, visual manifestations, and focal neurological deficits have been described.</p><h4>Pathology </h4><p>The term rhabdoid morphology is referring to the characteristic resemblance of the cells to a rhabdomyoblast without true skeletal muscle differentiation. The term malignant rhabdoid tumour (MRT) was first used to describe a distinctive paediatric renal tumour, the term was applied to similar extra-renal paediatric tumours. Rhabdoid cells show abundant eosinophilic cytoplasm, cytoplasmic hyaline inclusions, and eccentric nuclei <sup>4</sup>. </p><h6>Grading</h6><p>Generally, classified as WHO III malignant meningioma.</p><h4>Radiographic features</h4><p>Rhabdoid meningioma tends to have cystic and solid components with homogeneous enhancement of the solid component. There is extensive peri-tumoural oedema <sup>2</sup>. Bone destruction, indistinct margins and central necrosis are known to correlate with aggressiveness. </p><h5>MRI</h5><p>Signal characteristics that correlate with aggressive behaviour of meningiomas include:</p><ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.